Eli Lilly and Co (NYSE:LLY)

139.58
Delayed Data
As of Jan 17
 -1.85 / -1.31%
Today’s Change
101.36
Today|||52-Week Range
141.97
+6.20%
Year-to-Date
Eli Lilly's Shopping Spree Won't Stop With Dermira, CFO Shares Plans For More Deals In 2020
Jan 17 / MotleyFool.com - Paid Partner Content
Why AbbVie Could Be a Great Buy in 2020
Jan 13 / MotleyFool.com - Paid Partner Content
Incyte Stock Is Down: Buy the Dip?
Jan 15 / MotleyFool.com - Paid Partner Content
All the 2020 Pre-JPM News Healthcare Investors Need to Know
Jan 11 / MotleyFool.com - Paid Partner Content
Eli Lilly Releasing Cheaper Insulin Generic to Compete With Lispro Products
Jan 14 / MotleyFool.com - Paid Partner Content
Eli Lilly to Boost Its Dermatology Pipeline with $1.1 Billion Dermira Acquisition
Jan 10 / MotleyFool.com - Paid Partner Content
Will Theravance Biopharma Finally Break Out in 2020?
Jan 14 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close141.43
Today’s open140.88
Day’s range139.36 - 141.74
Volume5,393,587
Average volume (3 months)3,334,943
Market cap$134.0B
Data as of 6:30pm ET, 01/17/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+4.83%
Earnings growth (next 5 years)+10.70%
Revenue growth (last year)+7.36%
P/E ratio31.0
Price/Sales4.87
Price/Book15.01

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.82+1.62%
ABBVAbbVie-1.26-1.41%
SNYSanofi+0.05+0.10%
GSKGlaxoSmithKline+0.73+1.55%
Data as of 6:30pm ET, 01/17/2020

Financials

Next reporting dateJanuary 30, 2020
EPS forecast (this quarter)$1.51
Annual revenue (last year)$24.6B
Annual profit (last year)$3.2B
Net profit margin13.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Indianapolis, Indiana

Forecasts